surmount-1 tirzepatide three year efficacy outcomes just presented at #ObesityWeek2024 π πSustained weight loss of 22.9% or an average 54lbs over 3 years π½94% reduction in risk of progression to diabetes. Number Tolerability and Weight Reduction of
Pay in 4 interest-free payments of $5.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 20 - Aug 25

























